Eton Pharmaceuticals, Inc. · NASDAQ:ETON
Maier Paul V sold 50,000 Eton Pharmaceuticals, Inc. shares (Form 4/A)
Traded Aug 28, 2026 · Filed Aug 31, 2026
On Aug 28, 2026, Maier Paul V (Director) sold 50,000 Eton Pharmaceuticals, Inc. shares at an average US$59.07 for US$2.95M, leaving 72,245 shares. Filed Aug 31, 2026 (Form 4/A).
- Sold
- 50,000 shares
- Price
- US$59.07 average (US$58.64 to US$61.77)
- Value
- US$2.95M
- Holding after
- 72,245 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Common Stock | Option exercise | 50,000 | US$3.78 | 109,745 | Direct |
| Aug 28, 2026 | Common Stock | Sale | 36,387 | US$58.64 | 73,358 | Direct |
| Aug 28, 2026 | Common Stock | Sale | 13,485 | US$60.21 | 59,873 | Direct |
| Aug 28, 2026 | Common Stock | Sale | 128 | US$61.77 | 59,745 | Direct |
| Aug 28, 2026 | Common Stock | Option exercise | 12,500 | US$7.31 | 72,245 | Direct |